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Polymorphic rhoptry-secreted kinases (ROPs) are
essential virulence factors of Toxoplasma gondii. In
particular, the pseudokinase ROP5 is the major
determinant of acute virulence in mice, but the
underlying mechanisms are unclear. We developed
a tandem affinity protein tagging and purification
approach in T. gondii and used it to show that
ROP5 complexes with the active kinases ROP18
and ROP17. Biochemical analyses indicate that
ROP18 and ROP17 have evolved to target adja-
cent and essential threonine residues in switch
region I of immunity-related guanosine triphospha-
tases (GTPases) (IRGs), a family of host defense
molecules that function to control intracellular path-
ogens. The combined activities of ROP17 and
ROP18 contribute to avoidance of IRG recruitment
to the intracellular T. gondii-containing vacuole,
thus protecting the parasite from clearance in inter-
feron-activated macrophages. These studies reveal
an intricate, multilayered parasite survival strategy
involving pseudokinases that regulate multiple
active kinase complexes to synergistically thwart
innate immunity.
INTRODUCTION
Toxoplasma gondii is a widespread parasite that infects warm-
blooded vertebrates, leading to zoonotic infections in humans
(Dubey, 2010). The majority of isolates in North America and
Europe belong to one of three distinct lineages where type I
strains are acutely virulent, while type II are intermediate and
type III are avirulent in the laboratory mouse (Sibley and Ajioka,
2008). The ability to cross strains in the cat was exploited to
develop forward genetic strategies to map genes controlling dif-
ferences in acute virulence (Khan et al., 2005; Su et al., 2002).
Quantitative trait locus (QTL) mapping identified the active rhop-
try kinase ROP18 as the major determinant of the difference be-
tween highly virulent type I and avirulent type III parasites (Taylor
et al., 2006) and between intermediate virulence type II parasites
and avirulent type III parasites (Saeij et al., 2006). ROP18 hasCell Hseveral targets in the host cell, including immunity-related
GTPases (IRGs) (Fentress and Sibley, 2011) that function in
innate immunity and ATF6b (Yamamoto et al., 2011), a compo-
nent of the unfolded protein response that influences adaptive
immunity. IRGs are strongly induced by interferon gamma
(IFN-g) and are important in cell-autonomous restriction of
T. gondii and other intracellular pathogens (Taylor et al., 2007).
Preferential recruitment of IRGs to the nascent parasitophorous
vacuole membrane (PVM) surrounding susceptible strains of
T. gondii leads to disruption of the vacuole and parasite death
(Khaminets et al., 2010; Zhao et al., 2009). ROP18 from type I
strains is able to phosphorylate specific threonine residues in
switch region I of the GTPase domain of IRGs, and this modifica-
tion is likely responsible for inactivating the GTPase function,
thus preventing oligomerization and loading on the PVM (Fen-
tress et al., 2010; Steinfeldt et al., 2010). Although ROP18 from
both type I and type II strains is capable of enhancing virulence
when expressed in a type III background, which is normally
hypomorphic for ROP18 expression, type II strains are nonethe-
less susceptible to IRG recruitment (Khaminets et al., 2010; Zhao
et al., 2009), indicating that additional genes shared by type I and
III strains are important for acute virulence.
Forward genetic mapping of virulence differences between
strain types I and II and types II and III identified amajor virulence
locus encoding the pseudokinase ROP5 (Behnke et al., 2011;
Reese et al., 2011). Type I and III strains share a similar comple-
ment of ROP5 alleles that is necessary for acute virulence, while
type II strains contain a distinct cluster of ROP5 alleles that is
associated with lower virulence (Behnke et al., 2011; Reese
et al., 2011). The major type I allele of ROP5 interacts with
IRGs (Fleckenstein et al., 2012) and increases the kinase activity
of ROP18 (Behnke et al., 2012), consistent with the genetic evi-
dence that these two factors work together to enhance virulence.
However, the large phenotypic differences between the type I
Drop18 mutant, which is only slightly attenuated (Fentress
et al., 2010), and the Drop5mutant, which is completely avirulent
even at high doses (Behnke et al., 2011; Reese et al., 2011), sug-
gest that ROP5 also has other functions.
Here, we explored alternative roles for ROP5 using a
biochemical approach to identify binding partners by tandem
affinity purification (TAP) tagging and mass spectrometry
(MS). Our findings reveal that ROP5 is found in complexes
together with ROP18 and an unrelated, but active, kinase
called ROP17, which together mediate protection from the
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Figure 1. Isolation of Rhoptry Kinase Complexes from Toxoplasma gondii
(A) Generation of tetracycline-inducible tandem affinity purification (TAP) expression system in T. gondii. GT1 strain T. gondii cells expressing the tetracycline
repressor fused to YFP (Tet-Repressor-YFP) were transfected with plasmid constructs containing rhoptry kinases (ROP) that were C-terminally tagged with
calmodulin-binding peptide (CBP) and a protein A domain that provides a TAP tag under the control of a Tet-inducible promoter (TIP).
(legend continued on next page)
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Table 1. Proteins Identified in Mass Spectrometry Analysis of TAP-Purified Rhoptry Complexes
Protein ID T. gondiia Name/Motif Signal Peptide ROP5-TAP ROP18-TAP ROP17-TAP
TGGT1_042710b ROP5 (incomplete catalytic triad) yes 16 (136)c 20 (49) 8 (26)
TGGT1_063760b ROP18 yes 16 (49) 34 (187) ND
TGGT1_011620b ROP17 yes 12 (38) 16 (24) 12 (111)
TGGT1_083640 Ser/Thr phosphatase yes 18 (19) 14 (14) ND
TGVEG_030040d ROP2A (incomplete catalytic triad) yes 13 (43) 14 (21) 5 (10)
TGGT1_075470 ROP4/7 (incomplete catalytic triad) yes 13 (38) 14 (18) 5 (10)
TGGT1_062130 2-oxo acid dehydrogenase acyltransferase yes 13 (16) 16 (17) ND
TGGT1_034740 hypothetical yes 11 (17) 10 (13) ND
TGGT1_072150 SMC domain yes 10 (11) 10 (10) 11 (25)
TGGT1_108770 cyst matrix protein yes 10 (11) 7 (9) 7 (38)
TGGT1_087970 heat shock protein 70 yes 10 (11) 25 (136) 18 (23)
TGGT1_017550 GRA7 yes 9 (13) 10 (17) ND
TGGT1_088530 hypothetical yes 6 (7) 6 (7) ND
TGGT1_053780 hypothetical yes 6 (7) 7 (7) ND
TGGT1_085550 rhoptry surface protein, putative yes 5 (12) 5 (8) ND
TGGT1_126670 ROP8 (incomplete catalytic triad) yes 5 (7) 19 (28) ND
See also Table S1.
aThe cutoff for inclusion of individual proteins into this list was set at five or more unique peptide matches with a probability of 0.95 or above.
bBait proteins.
cNumber of unique peptides is indicated, and number in parenthesis indicates the number of spectra detected for each protein. Proteins lacking a
signal peptide were classified as common contaminants (Table S1). ND, none detected.
dGene models for ROP2A in the GT1 strain were not available.
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Purification of Rhoptry Kinase Complexes
To identify binding partners of ROP5, we developed a TAP strat-
egy to isolate native complexes from T. gondii tachyzoites. We
engineered a T. gondii cell line constitutively expressing a tetra-
cycline (Tet) repressor-YFP fusion protein (van Poppel et al.,
2006) to provide a background for introducing Tet-inducible
expression constructs (Figure 1A). The major type I allele of
ROP5 (H allele) (Behnke et al., 2011) was expressed as a TAP-
tag fusion with a calmodulin-binding peptide and a protein A
moiety (Puig et al., 2001). Overexpression of the TAP-tagged
ROP5 was induced with tetracycline (Figure 1B). Purification of
the ROP5 complex (Figure 1C) and subsequent MS analysis
identified approximately 15 proteins, each with at least 5 unique
peptides (Table 1). The ROP5-TAP complex included the
previously characterized active kinase ROP18, as well as an un-
characterized ROP kinase called ROP17, which was initially
described as a component of purified rhoptries (Bradley et al.,
2005) (Table 1). Other prominent components included a Ser/
Thr phosphatase, ROP pseudokinases such as ROP2/ROP8
and ROP4/ROP7, as well as a variety of other proteins (Table 1).
Additional proteins lacking predicted signal peptides were not
studied further, since ROP5 is present in the secretory pathway
(Table S1 available online).(B) Clonal parasite lines expressing ROP5-TAP, ROP18-TAP, or ROP17-TAP we
separated on 8%–16% SDS-PAGE gels, western blotted with antibodies agains
stained gels are shown beneath.
(C) TAP purifications of rhoptry kinase-CBP complexes. Final elutions were sep
indicate differently processed forms of the tagged rhoptry kinases. Representati
Cell HTo validate the associations between ROP kinases and ROP5,
we performed reciprocal TAP of both ROP18 and ROP17 TAP-
tagged lines (Figure 1B). Analysis of the ROP18-TAP complex
(Figure 1C, middle panel) confirmed binding with ROP5 and
also detected peptides for ROP17, albeit to a lesser extent
(Table 1). The ROP17-TAP (Figure 1C, right panel) also validated
the association of ROP5, although this complex did not contain
ROP18 (Table 1). GRA7, which also immunoprecipitates with
ROP18 (Alaganan et al., 2014; Dunn et al., 2008), was also
seen in the ROP5 and ROP18 complexes, although not in the
ROP17 complex (Table 1). Additionally, all three TAPs contained
an SMC domain-containing protein, predicted to be a compo-
nent of chromatin-modifying complexes, Hsp70 (a chaperone
involved in protein folding), and a cyst matrix protein, which is
a component of the matrix of tissue cysts that is upregulated in
bradyzoites (Parmley et al., 1994). Given their diverse functions
and lack of obvious connection with the interface at the PVM,
these later proteins may simply represent copurifying contami-
nants, and they were not pursued further here (Table 1).
To further characterize the ROP kinase complexes, we sub-
jected whole-cell parasite extracts to sedimentation on 10%–
30% glycerol gradients followed by SDS-PAGE and western
blotting (Figure 2A). ROP5, ROP17, and ROP18 sedimented
broadly in the 4S–20S range, suggesting that they comprise
a variety of high molecular weight complexes. ROP18 hasre grown in the absence () or presence (+) of Tet for 48 hr. Cell extracts were
t CBP, and imaged using LI-COR specific secondary antibodies. Coomassie-
arated on 8%–16% SDS-PAGE gels and stained with SYPRO Ruby. Arrows
ve of two similar experiments.
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Figure 2. Characterization of the Rhoptry Kinase Complexes
(A) Glycerol gradient separation of ROP kinases. Whole-cell extracts of T. gondii were fractionated on 10%–30% glycerol gradients, resolved on 8%–16% SDS-
PAGE gels, western blotted with the antibodies shown, and detected using LI-COR specific secondary antibodies. Sedimentation coefficients were determined
using standards run in parallel; lower gel was stained with SYPRO Ruby.
(B) Localization of ROP17 in infected host cells. RHDku80 T. gondii parasites were used to challenge HFF monolayers for 30 min in 1 mM cytochalasin D to block
invasion and visualize proteins secreted into evacuoles. Monolayers were fixed and permeabilized with 0.05% saponin.
(legend continued on next page)
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while ROP17 has not yet been examined for its role in intracel-
lular survival or acute virulence. Hence, we focused our studies
on defining the role of ROP17 as a binding partner of ROP5.
ROP17 and ROP5 Are Secreted in Evacuoles and
Localized to the External Face of the PVM
Similar to other ROP2 family members, ROP17 contains an
N-terminal amphipathic region that targets heterologous re-
porters to the PVM (Reese and Boothroyd, 2009). To examine
the location of endogenous ROP17, human foreskin fibroblast
(HFF) monolayers were infected with T. gondii in the presence
of cytochalasin D, which blocks invasion but allows secretion
of rhoptry contents in evacuoles into the host cell (Ha˚kansson
et al., 2001). Both ROP17 and ROP5 were found in secreted
evacuoles by immunofluorescence (IF) microscopy (Figure 2B).
In cells that were selectively permeabilized with digitonin,
ROP5 and ROP17 were found to colocalize on the cytosolic sur-
face of newly formed vacuoles (Figure 2C), a pattern that was
maintained for up to 16 hr postinfection (Figure 2D). Under these
selectively permeable conditions, ROP17 stained the PVM, while
the parasite surface antigen (SAG1) was not detectable (Figures
S1A and S1B). The localization of ROP17 to the parasite vacuole
external face was not dependent on the presence of ROP5, as
vacuoles surrounding RHDrop5 parasites had a normal distribu-
tion of ROP17 (Figures S1C and S1D). In fully permeabilized cells
examined at later stages of infection, dividing parasites showed
clear colocalization of ROP17 and ROP5 within apical rhoptry
organelles (Figure 2E). Collectively, these data suggest that
ROP5 and ROP17 are found in a complex that localizes to the
external face of the PV.
ROP17 Is under Positive Selection, and Its Native
Complex Displays Robust Kinase Activity
Phylogenic analysis of ROP17 in representative strain types I, II,
and III revealed the presence of a shared allele in the type II and III
lineages that differed at 24 amino acids from that found in type I
(Figure 3A). Examination of the cumulative differences in synon-
ymous (S) and nonsynonymous (NS) mutations in the two alleles
of ROP17 (Figure 3B) demonstrated a pNS/pS ratio of 1.50 (Fig-
ure 3C). Hence, ROP17 is polymorphic and under positive selec-
tive pressure, albeit to a lesser extent than either ROP18 or ROP5
(Peixoto et al., 2010).
ROP17 contains a conserved catalytic triad that predicts it to
be an active Ser/Thr protein kinase (Hanks and Hunter, 1995).
We compared the isolated ROP17-TAP and ROP5-TAP com-
plexes to recombinant ROP17 (rROP17) using an in vitro kinase
reaction in the presence of [g-32P]ATP and the heterologous sub-
strate casein. The ROP5-TAP complex showed strong activity
(Figure 3D), with a result likely due to its interaction with both
ROP18 and ROP17, since ROP5 lacks demonstrable activity
when expressed alone as a recombinant protein (Behnke et al.,
2012; Reese and Boothroyd, 2011). The activity of the native(C and D) Alternatively, parasites were allowed to invade HFF cells without cyto
digitonin to selectively expose the cytosolic surface of the PVM.
(E) To detect proteins localized to the rhoptries, HFF monolayers were fixed at 16
incubated with mouse anti-ROP17, visualized by goat anti-mouse immunoglobuli
by goat anti-rabbit IgG conjugated to Alexa 488 (green). Scale bars, 5 mm. Repre
Cell HROP17-TAP complex was far greater than that of rROP17 alone
(Figure 3D), suggesting that additional factors present in the
complex in vivo contribute to its activity. To determine if ROP5
was required for the activity of ROP17, we immunoprecipitated
ROP17 from wild-type (Dku80) T. gondii lysates as well as from
several deletion mutant lines. Precipitated ROP17 complexes
were subjected to an in vitro kinase reaction in the presence of
the synthetic substrate dephosphorylated myelin basic protein
(dMBP) (Figure 3E) or the IRG protein Irgb6 (Figure 3F). Although
the activity of ROP17 was absent in the Drop17 background,
ROP17 did not require the presence of ROP5 for activity in vitro.
ROP17 Contributes to Virulence of Type I Parasites
Based on the finding that ROP5 is found in complexes with
ROP17, we hypothesized that one contribution of ROP5 to acute
virulence might be due to of its interactions with ROP17. We
generated aDrop17 deletionmutant that was confirmed by diag-
nostic PCR (Figure S2A) and western blotting in comparison with
Drop18 and Drop5mutants described above (Figure 4A). Inocu-
lation of CD-1 mice with 100 Drop17 T. gondii parasites resulted
in slight attenuation of virulence relative to the parental control
(Dku80) (Figure 4B). To address the possibility that ROP17 and
ROP18 might be partially redundant, we deleted ROP18 in
the Drop17 background (Figures 4A and S2A–S2C). Unlike
either of the single mutants, the Drop17Drop18 mutant was
completely avirulent in mice at a dose of 100 parasites
(Figure 4B). To examine the magnitude of parasite attenuation
in theDrop17Drop18 line, we infected CD-1mice with increasing
doses of parasites, establishing that thismutant has a lethal dose
50 (LD50) of 106, a >4-log increase over the single knockout
mutants (Figure 4C). Various attempts to complement the
ROP17 gene in this background proved unsuccessful; therefore,
we generated the double deletion mutant in the reverse order by
deleting ROP17 on the previously generated Drop18 back-
ground (Figure S2D). Two independent double Drop18Drop17
mutants recapitulated the decreased virulence of original
Drop17Drop18 mutant in the mouse (Figures S2E and S2F).
Attenuation of Drop17 Parasites Is Due to Greater
Immunological Control
To test whether the virulence defect of the Drop17Drop18
mutant was due to increased susceptibility to immune control,
we infected Ifngr/ mice and monitored survival. Infection of
Ifngr/ mice with Drop17Drop18 parasites resulted in 100%
mortality by 10 days postinfection, while C57BL/6 control mice
survived (Figure 5A). Consistent with a requirement for T cell-
mediated IFN-g production, Rag1/ mice were susceptible to
challenge with Drop17Drop18, albeit with a slightly delayed
death phenotype relative to wild-type T. gondii (Dku80) (Fig-
ure S3A). In contrast, X-CGD/ mice, which are deficient in
the phagocyte oxidase-mediated respiratory burst (Pollock
et al., 1995), showed no change in the attenuation of the
Drop17Drop18 mutant (Figure S3B). Nos2/ mice, which arechalasin D for 30 min (C) or 16 hr (D), fixed, and permeabilized with 0.002%
hr postinfection and fully permeabilized with 0.1% Triton X-100. Samples were
n G (IgG) conjugated to Alexa 594 (red), and rabbit antisera to ROP5, visualized
sentative of two similar experiments. See also Figure S1.
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Figure 3. Allelic Diversity and Kinase Activity of ROP17
(A) Phylogenic analysis and neighbor-joining tree of ROP17 sequences revealed two alleles in the three clonal lineages (i.e., types I, II, and III). Scale, substitutions
per site.
(B) Cumulative nonsynonymous (nonsyn) and synonymous (syn) polymorphisms in ROP17 genes from (A).
(C) Proportion of nonsynonymous (pNS) versus synonymous (pS) substitutions for the ROP17 alleles.
(D) Kinase activities of the purified TAP complexes versus rROP17. Casein (20 mg) (arrow) was incubated in a kinase reaction with approximately 2 ng of ROP17-
TAP and ROP5-TAP, or alternatively 1 mg of rROP17, for 30 min in the presence of [g-32P]ATP. Kinase reaction products were resolved on 8%–16% SDS-PAGE
gels followed by transfer onto nitrocellulose and phosphorimager analysis.
(legend continued on next page)
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Figure 4. ROP17 and ROP18 Act Synergisti-
cally to Control Acute Virulence in Type I
Parasites
(A) Western blot analysis of deletion mutants. Cell
lysates from the wild-type (Dku80) and deletion
mutants were separated on 8%–16% SDS-PAGE
gels, western blotted with primary antibodies, and
imaged on the Odyssey imager using LI-COR
specific secondary antibodies.
(B) Survival of CD-1 mice challenged by i.p.
inoculation with 102 wild-type (Dku80) or mutant
parasite lines (n = 5 per group). PI, days post-
inoculation.
(C) Dose response of survival of CD-1 mice
challenged by i.p. inoculation with the
Dku80Drop18Drop17 double mutant (n = 5 per
group). PI, days postinoculation. Representative
of three or more experiments. See also Figure S2.
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1995), displayed an intermediate phenotype characterized by
delayed death associated with late-stage neurological disease,
likely due to an inability to control low-level infection in the brain
(Figures S3C–S3F). All of the mutants showed similar levels of
replication inmacrophages activated only with IFN-g and greater
control of replication (stasis) in macrophages activated with
both IFN-g and lipopolysaccharide (LPS) (Figure S3G), suggest-
ing they are not differentially sensitive to nitric oxide (NO).
Taken together, these findings indicate that the attenuation of
Drop17Drop18mutants is due to an inability to effectively thwart
IFN-g-mediated innate immune defenses, rather than an inability
of parasites to grow within the host.
Resistance to the Host IRG Pathway Is Partially
Mediated by ROP17
The primarymechanism of IFN-g-mediated control of T. gondii in
the mouse is due to upregulation of IRGs, which are recruited to
susceptible parasite-containing vacuoles that are subsequently
destroyed (Howard et al., 2011). To evaluate the role of this
pathway, we infected IrgM3/ mice with the Drop17Drop18
mutant (Figure 5B). We observed a complete reversion to viru-
lence in the IrgM3/ mice (Figure 5B), suggesting that ROP17
may also operate in this pathway. To determine if the attenuation
of the single Drop17 mutant and the Drop17Drop18 mutant was
due to enhanced susceptibility to IRG-mediated clearance, RAW
264.7 mouse macrophages were activated with IFN-g and LPS(E and F) ROP17 immunoprecipitated fromwild-type (Dku80) or mutant parasite lysates was incubated in a kin
(E) or Irgb6 (F) in the presence of radiolabelled [g-32P]ATP. Reaction products were resolved by 8%–16% SD
phosphorimager analysis. Total parasite lysates were separated on 8%–16% SDS-PAGE gels, western blo
rabbit anti-ROP5 (Rb a-ROP5), and imaged on the LI-COROdyssey Imaging System. The asterisk (*) in (F) den
similar experiments.
Cell Host & Microbe 15, 537–and examined for the ability to clear para-
site infection during the first 20 hr postin-
fection. Parasites deficient in ROP17
showed a significant increase in suscep-
tibility to clearance by IFN-g-activated
macrophages relative to wild-type para-
sites, and this deficiency was significantlyincreased in the double deletion mutant (Figure 5C). To deter-
mine if clearance was IRG mediated, we examined the loading
of Irga6 and Irgb6 on the PVM in activatedmacrophages infected
with wild-type and mutant parasites at 30 min postinfection.
Although deletion of rop17 alone resulted in only a modest
increase in loading of IRGs, Drop17Drop18 parasites showed
significantly increased loading of Irgb6 and Irga6 (Figures
5D–5G). Similar results were obtained when we quantified the
intensity of Irgb6 and Irga6 loading onto the PVM-surrounding
parasites (Figures S4A and S4B). In addition, similar levels of
IRG loading were observed at 2 hr postinfection (Figures S4C
and S4D). Collectively, these findings indicate that both ROP17
and ROP18 contribute to the resistance of T. gondii to clearance
by the IRG pathway.
ROP17Phosphorylates aConservedMotif in SWI of IRGs
and Inhibits IRG Polymerization
To determine the substrate preference for ROP17, we performed
an in vitro kinase assay using a positional scanning peptide array
(Turk et al., 2006). Similar to ROP18 (Fentress et al., 2010),
ROP17 showed a strong preference for Thr over Ser as the target
of phosphorylation (Figure 6A). Using the phosphorylation inten-
sity data from the peptide array, we generated a probability
matrix motif for ROP17, which revealed a slight preference for
hydrophobic residues surrounding the phosphorylation site (Fig-
ure 6B). We then used the probability matrix to define preferred
Thr-containing motifs within the family of mouse IRGs, and thease reaction with the heterologous substrate dMBP
S-PAGE, followed by transfer to nitrocellulose and
tted (WB) with mouse anti-MIC2 (Mo a-MIC2) and
otes likely heavy-chain IgG. Representative of three
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Figure 5. IFN-g Signaling and IRG-Mediated Clearance Is Required for Control of ROP17-Deficient Parasites
(A) Survival of Ifngr1/ or C57BL/6 mice infected by i.p. inoculation with 103 parasites (n = 5 per group).
(B) Survival of IrgM3/ or C57BL/6 control mice infected by i.p. challenge with 103 parasites (n = 5 per group).
(C) In vitro clearance of parasites in RAW 264.7 mouse macrophages that were activated with IFN-g (150 units) and LPS (10 ng/ml). Infection level at 20 hr
postinfection expressed as a percentage of initial infection as determined by in-cell western using the LI-COR Odyssey Imaging System. Means ± SEM; n = 3
combined independent experiments.
(D–G) Immunofluorescence staining on parasite-containing vacuoles in activated RAW 264.7 mouse macrophages (IFN-g, 100 units; LPS, 0.1 ng/ml) at 30 min
postinfection of Irgb6 (D), and its quantification (E), or Irga6 (F), and its quantification (G). Scale bar, 5 mm. The percentage of Irgb6 or Irga6-positive vacuoles was
determined by comparison to staining with the PVM markers GRA5 or GRA7, respectively. Monolayers were stained with a rabbit polyclonal anti-irgb6 (green),
monoclonal antibody (mAb) 10D7 to Irga6 (green), mAb Tg17-113 to GRA5 (red), or rabbit polyclonal anti-GRA7 (red) and detected with Alexa Fluor conjugated
secondary antibodies (DAPI, blue). Means ± SEM; n = 3 samples each from three combined experiments. Student’s t test; *p% 0.05, **p% 0.01, and ***p%
0.005. See also Figures S3 and S4.
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and ROP18. The highest-scoring match corresponded to a
highly conserved site within switch region I (SWI), where the
preferred ROP17 motif was centered on Thr102, while the
ROP18 motif was centered on Thr108 (Figure 6C). The prefer-
ence of ROP17 for Thr102 and ROP18 for Thr108 was predicted
for numerous members of the IRG family (Figure S5A). In order to
test the target prediction, we performed an in vitro kinase assay
on recombinant Irgb6 and Irga6 with and without the addition of
ROP5.We observed that ROP17 prefers Irgb6 as a substrate and
that, in contrast to what was observed for ROP18 (Behnke et al.,
2012), the activity of ROP17 was unaltered by the addition of
ROP5 (Figure 6D). MS analysis of the ROP17 phosphorylated
Irgb6 protein revealed that the only high-confidence phosphory-
lation site corresponded to Thr102, as predicted by the motif
analysis (Figure 6E). SemiquantitativeMS analysis demonstrated
a greater than 8-fold relative preference for Thr102 over Thr107,
while phosphorylation of Thr108 was not observed (Figures 6F
and S5B–S5E).
To examine whether phosphorylation of Irgb6 by ROP17
affected its ability to form higher-order polymers, we combined
Irgb6 in the presence of GTP with increasing amounts of
rROP17 protein and analyzed the products by native PAGE gel
followed by western blotting (Figure 6G). We observed that
Irgb6 incubated without GTP formed primarily monomers,
dimers, and tetramers (Figure 6G). In contrast, in the presence
of GTP, Irgb6 formed large polymers over 720 kDa, which were
more evident on overexposure (Figure 6G, right panel). Addition
of increasing amounts of ROP17 to the reaction resulted in a
concomitant decrease in the amount of Irgb6 polymer (Fig-
ure 6G). Probing native western blots with an antibody against
phosphothreonine demonstrated that large oligomers of Irgb6
comprise the major phosphorylated form, despite being less
abundant (Figure 6H). ROP17 was not incorporated into the
high molecular weight oligomeric forms of Irgb6 (Figure S6A)
and therefore likely does not contribute significantly to this phos-
phorylation signal, despite being able to autophosphorylate
(Figure 6D). At the highest concentration of ROP17 tested, phos-
phorylatedmonomers and dimers accumulated, likely as a result
of disassembly of phosphorylated polymers (Figures 6G and 6H).
Additionally, the loss of the Irgb6 oligomeric forms in the pres-
ence of ROP17 was observed in glycerol gradients (Figure S6B).
These results suggest that the preferred substrate for ROP17 is
the Irgb6 polymer and that phosphorylation leads to disassembly
into monomers and dimers.
DISCUSSION
We utilized TAP tagging of proteins in T. gondii to demonstrate
that the pseudokinase ROP5 exists in complexes with two active
Ser/Thr kinases: ROP18, previously known from genetic interac-
tion studies, and ROP17, a virulence factor identified in this
study. ROP17 also targets members of the IRG family to prevent
clearance in IFN-g-activated macrophages, thus establishing a
cellular basis for its synergy with ROP18. The substrate prefer-
ences of these two kinases are tailored to target two conserved
residues in SWI that are essential for IRG function. Moreover,
unlike previous mechanisms that have been proposed for IRG
disruption, ROP17 targets IRG oligomers, leading to their disas-Cell Hsembly, a process that may contribute to protection of the PVM
in infected macrophages. Taken together, our findings reveal
that T. gondii has evolved a multilayered system of effectors to
specifically target the diverse array of IRGs encountered in
IFN-g-activated cells, thereby thwarting innate immunity.
TAP tagging has been a useful strategy for identifying com-
plexes in a variety of organisms (Puig et al., 2001); therefore,
we undertook the development of this technology in T. gondii.
TAP tagging of ROP5 demonstrated that it exists in two distinct
complexes, each containing predominately ROP18 or ROP17,
as well as related ROP pseudokinases ROP2/ROP8 and
ROP4/ROP7. It is uncertain what role these pseudokinases
play in the complexes studied here, although deletion of the
ROP2/ROP8 (Alaganan et al., 2014) or ROP4/ROP7 (R.D.E.
and L.D.S., unpublished data) loci does not affect acute viru-
lence in the mouse. GRA7 was also found in the complex with
ROP18, consistent with the recent report that it acts synergisti-
cally to affect IRG recruitment and virulence (Alaganan et al.,
2014). The migration of ROP5, ROP17, and ROP18 on gradients
suggests that they are components of heterogeneous com-
plexes of various compositions. Further work will be required
to define the exact composition of these complexes in the secre-
tory pathway and on the PVM, where they coexist.
ROP kinases are expanded in the genome of T. gondii, with
20 genes that are predicted to encode active kinases and a
similar number predicted to encode pseudokinases (Peixoto
et al., 2010). ROP18 is a member of the subgroup known as
ROP2-like genes, while ROP17 is more divergent, as shown by
comparison of their kinasedomains (Peixoto et al., 2010). Despite
this divergence, ROP17 andROP18 target a common pathway in
the host by phosphorylating members of the IRG family. Consis-
tentwith their overlapping functions, singledeletion of either gene
hadonly amodest effect on virulence, characterizedby adelayed
time to death, but a nonetheless lethal outcome even with low
inocula (this study and Fentress et al., 2010). In contrast, the
Drop17rop18mutant has an LD50 of106,which ismore severely
attenuated yet still not as compromised as the Drop5 mutant
(Behnke et al., 2011; Reese et al., 2011). Although previous
studies have suggested that the Drop5 mutant does not persist
in wild-type mice (Behnke et al., 2012), we observed increased
CNS pathology in mice infected with the Drop17Drop18 double
mutant, consistent with an increased capacity to disseminate
and cause low-grade infection. Importantly, the phenotypes of
all threemutants are completely reverted in Ifngr1/mice,which
cannot signal in response to IFN-g (Yap and Sher, 1999), and in
IrgM3/ mice, which lack a functional IRG pathway (Taylor
et al., 2000). Thus, although ROP5 and ROP17 may have other
targets beyond IRGs, avoidance of this early innate pathway is
one of their critical functions.
Previous studies indicate that the primary mechanism that
IFN-g-activated cells in the mouse use to control T. gondii is
upregulation of the IRG pathway (Howard et al., 2011). Together
with ROP18 (Behnke et al., 2011; Reese et al., 2011) and ROP5
(Behnke et al., 2011; Reese et al., 2011), our findings indicate
that ROP17 works collectively to block the IRG pathway. This
triad of virulence effectors is most effective in type I parasites,
which contain a highly expressed ROP18 and virulence-
enhancing ROP5 locus, while type II strains have an active
ROP18 but avirulent ROP5 locus (Hunter and Sibley, 2012).ost & Microbe 15, 537–550, May 14, 2014 ª2014 Elsevier Inc. 545
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having the virulence-enhancing ROP5 locus, which is ineffective
in the absence of highly expressed ROP18 (Hunter and Sibley,
2012). Although ROP17 participates in acute virulence, previous
genetic mapping studies failed to reveal a QTL for this locus,
even though it is polymorphic with type II and III strains, sharing
an allele that is distinct from type I. Further genetic and biochem-
ical studies may clarify whether ROP17 alleles act differently in
combination with ROP18 and/or ROP5.
Consistent with the fact that ROP17 and ROP18 act synergis-
tically to affect acute virulence, they target slightly different
conserved residues in a common set of host targets. In both
cases, they show a preference for phosphorylating SWI within
the GTPase domain of IRGs. We show that ROP17 shows a
preference in vitro for Irgb6 over Irga6, while previous studies
indicate that ROP18 prefers Irga6 (Steinfeldt et al., 2010),
although it also phosphorylates both Irgb6 and Irgb10, albeit
less avidly (Fentress et al., 2010). Despite these in vitro prefer-
ences, increased recruitment of both Irgb6 and Irga6 was seen
in both single mutants, suggesting that substrate preferences
may be modulated in vivo or that these host proteins work
together in complexes. ROP18 was previously shown to phos-
phorylate multiple Thr residues in SWI of Irga6 (Thr102, Thr108)
(Steinfeldt et al., 2010), as well as in Irgb6 (Thr102, Thr107,
Thr108) (Fentress et al., 2010); however, no quantitative assess-
ment of the relative preference for phosphorylation of these res-
idues was provided. In the present study, we reexamined the
substrate preference motifs for both kinases, revealing that
ROP17 prefers to phosphorylate Thr102, while ROP18 prefers
Thr108. We confirmed that ROP17 prefers Thr102 over Thr108
in Irgb6 using a semiquantitative MS approach, thus validating
this prediction for at least one substrate. These two Thr residues
are conserved in many IRG family members, yet they are distinct
from SWI of other small GTPases, suggesting that these kinases
have evolved to specifically target IRGs. Previous mutational
studies demonstrated that Thr102 and Thr108 are essential for
GTPase activity and oliogomerization of Irga6 (Steinfeldt et al.,
2010), suggesting that phosphorylation of these residues ren-
ders the protein inactive. Hence, the activities of ROP17 and
ROP18 should combine to phosphorylate IRGs on key Thr resi-Figure 6. Phosphorylation of IRGs by ROP17 In Vitro
(A) Phosphopeptide array for in vitro ROP17 kinase reaction. For each position (y a
varied. Phosphoimager analysis of a [g-33P]ATP kinase reaction was converted i
(B) Probability matrix for ROP17 determined by WebLogo3.0 from the positional
(C) MEME sequence motifs for ROP17 and ROP18. Positional scoring matrices w
using Prophet, and the top 5 candidates were used to generate MEME sequenc
ClustalX alignment of the IRG family to emphasize the conserved switch region I
(D) In vitro kinase activity of rROP17 (1 mg/reaction) on the substrates, recombinan
the presence of radiolabelled [g-32P]ATP. Reaction products were separated on
Representative of two experiments.
(E) Mass spectrometry analysis of tryptic peptides derived from in vitro phospho
(F) Semiquantitative analysis using liquid chromatography-tanden mass spe
(664.3 m/z ± 15 ppm).
(G) Polymerization of Irgb6 following phosphorylation by rROP7 in vitro. A kinase re
30 min at 37C, followed by native PAGE gel (8%–16%) separation and western
panel is an overexposure of the gel on the left. Irgb6 oligomers (denoted as A) a
centration below the gel.
(H) The blot in (G) was reprobed with Rb antibodies against phosphothreonine to v
(A) and monomer/dimer (B) are shown as ratios below the gel. Western blots wer
Representative of three similar experiments. See also Figures S5 and S6.
Cell Hdues, blocking their oligomerization and preventing assembly
on the PVM. Consistent with this prediction, the single Drop17
and Drop18 mutants show increased IRG recruitment in IFN-g-
activated macrophages, and recruitment is further enhanced in
the Drop17rop18 mutant.
Previous studies have stressed the role of ROP5 in blocking
IRG oligomerization in vitro as detected by light scattering,
suggesting a noncatalytic role for ROP5 in sequestering IRGs
(Fleckenstein et al., 2012). Additionally, ROP5 was shown to
enhance the phosphorylation of IRGs by regulating ROP18
(Behnke et al., 2012). Collectively, these activities are thought
to contribute to avoidance of IRG recruitment to the PVM. How-
ever, both of these models postulate interactions between para-
site effectors and monomeric IRGs, which normally only exist in
complex with IRGM proteins on endomembranes (Howard
et al., 2011). In contrast, IRGs oligomerize and assemble on the
PVM owing to the absence of regulatory IRGM proteins, leading
to destruction of the invading pathogen (Haldar et al., 2013). The
activity of ROP17 is particularly interesting in this light, as it is
shown to preferentially target IRG polymers. Native gel analysis
indicates that ROP17 prefers to phosphorylate IRG oligomers
and results in their disassembly, perhaps making monomers
available for ROP5 and/or ROP18 to act on further. In this regard,
it is intriguing that recent studies have shown that GRA7 can acti-
vate IRG assembly in vitro, leading to its rapid depolymerization,
an effect that may also make monomeric substrates available to
ROP5 and ROP18 (Alaganan et al., 2014). Unlike ROP18, ROP17
does not appear to rely on ROP5 for its activity in vitro. However,
the formation of complexes between ROP5 and ROP17 may
facilitate recruitment of substrates or enhance activity in vivo to
improve the efficiency of combating the IRG pathway.
Our findings reveal an intricate interaction between a multi-
component innate defense system that encodes the divergent
and amplified IRG genes in the mouse and an expanded family
of virulence-promoting secretory proteins in the parasite
T. gondii. These virulence effectors consist of both active and
pseudokinases that operate in complexes at the host-parasite
interface on the surface of the PVM. The heterogeneous nature
of the ROP complexes is presently not fully understood, but their
various different states may be involved in regulation, substratexis), a single amino acid was held constant (x axis), while all other positions were
nto a heatmap. Representative of two experiments.
scoring matrix derived from the heatmap in (A).
ere used to determine probable targets within each member of the IRG family
e motifs. The top scoring MEMEs for ROP17 and ROP18 are placed above a
(SWI) location of their respective predicted phosphorylation sites.
t Irga6 and Irgb6 (rIrgb6 and rIrga6; 2 mg each), incubated for 40 min at 30C in
10% SDS-PAGE gels that were dried and imaged by phosphoimager analysis.
rylation of recombinant Irgb6 by rROP17. Representative experiment.
ctrometry (LC-MS/MS) of phosphorylated peptides of GAAPTGAIETTMK
action combining rROP17 and rIrgb6 in the presence of GTPwas carried out for
blotting for Irgb6. SDS-PAGE followed by western blotting (lower panel). Right
nd monomer/dimers (denoted as B) are shown as ratios at each ROP17 con-
isualize the phosphorylated proteins. Levels of phosphorylated Irgb6 oligomer
e imaged on the Odyssey imager using LI-COR specific secondary antibodies.
ost & Microbe 15, 537–550, May 14, 2014 ª2014 Elsevier Inc. 547
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parallel systems likely reflects the coevolving relationship be-
tween T. gondii and themouse as an important host for transmis-
sion. Curiously, for most of the active kinases in T. gondii, there is
no overt phenotype for single gene deletionmutants when tested
in the mouse (R.D.E. and L.D.S., unpublished data). Instead, the
tripartite group of ROP5, ROP18, and ROP17 appears to control
the major outcome of acute infection in the mouse. This pattern
suggests that other ROPs either have redundant and overlap-
ping functions or that are important in other contexts, such as
manipulating the many other hosts of T. gondii. Hence, the
remarkable complexity of host innate defense and pathogen
virulence traits revealed here is likely to be mirrored in other
settings where this highly successful parasite has established
a niche.
One potential example of other roles for ROP kinaseswould be
additional host defense pathways, such as guanylate-binding
proteins (GBPs). Although IRGs are not widely distributed
outside of rodents, and are almost absent in humans, the related
GBP family is found more widely (Kim et al., 2012). GBPs have
been implicated in host resistance to a number of pathogens in
the mouse (MacMicking, 2012), including T. gondii (Degrandi
et al., 2013; Selleck et al., 2013; Yamamoto et al., 2012).Whether
they prove to be important in innate immunity in other hosts, and
if they are targets of intervention by ROP kinases, will be the
subject of future studies.
EXPERIMENTAL PROCEDURES
Parasite Growth and Mouse Infections
Animals were maintained in an Association for Assessment and Accreditation
of Laboratory Animal Care approved facility, and the Institutional Care Com-
mittee at Washington University in St. Louis, School of Medicine, approved
all protocols. Tachyzoites of T. gondii strains were propagated in human
foreskin fibroblasts and purified as described previously (Fentress et al.,
2010). Knockout mutants were generated in the RHDku80Dhxgprt strain, as
described previously (Behnke et al., 2012; Behnke et al., 2011). Complete lists
of parasite strains, primers, and plasmids used are found in Tables S2–S4.
Age- and sex-matched mice from wild-type and knockout backgrounds (see
Supplemental Information) were challenged by intraperitoneal (i.p.) injection
with parasites, and cumulative mortality was determined at 30 days postinjec-
tion (Su et al., 2002). Tissues from chronically infected mice were examined
microscopically to evaluate histopathology.
In Vitro Infection Studies
The distribution of host and parasite proteins within infected cells was
determined by immunofluorescence (IF) staining, as described previously
(Fentress et al., 2010) (see Supplemental Information). Recruitment of host
IRGs to the PVM was evaluated at 30 min and 2 hr postinfection, as
described previously (Fentress et al., 2010). The distribution of parasite
proteins on the PVM was determined using Triton X-100 to fully permea-
bilize cells versus digitonin to partially permeabilize infected cells, as
described previously (Alaganan et al., 2014). Control of parasite replication
in IFN-g-activated RAW cells (150 units/ml IFN-g, 10 ng/ml LPS) was deter-
mined using an in-cell western protocol (see Supplemental Information)
imaged on the Odyssey infrared imager (LI-COR Biosciences). Induction of
stasis was monitored following infection of IFN-g-activated RAW 264.7
mouse macrophages (alone or in combination with LPS) for 20 hr followed
by staining for SAG1 and counting of parasites/vacuole (see Supplemental
Information).
In Vitro Protein Studies
The ROP17 coding sequence (including amino acids 22–608) (TgGT1_011620)
was amplified by genomic DNA from the type I RH strain of T. gondii using548 Cell Host & Microbe 15, 537–550, May 14, 2014 ª2014 Elsevier IiProof High-Fidelity polymerase (Bio-Rad), expressed in E. coli, purified, and
used to generate a polyclonal antisera in mice (see Supplemental Information).
Recombinant ROP5, ROP18, and IRG proteins were purified as described pre-
viously (Behnke et al., 2012; Fentress et al., 2010). Immunoprecipitations,
western blotting, and in vitro kinase assays were performed as described
previously (Behnke et al., 2012; Fentress et al., 2010). The phosphorylation
motif for ROP17 was defined as described previously (Fentress et al., 2010;
Turk et al., 2006). Whole-cell extracts of T. gondii were separated on 10%–
30% linear glycerol gradients centrifuged in a Beckman SW 41 rotor at
111,000 3 g for 20 hr and analyzed by SDS PAGE. Purified proteins were
resolved on 8%–16% native PAGE gels electrophoresed at 4C for 20 hr at
40 V, followed by western blotting. Further details can be found in the Supple-
mental Information.
Generation of Inducible TAP-Tag System for T. gondii
The TAP-tagging approach was adapted from previous methods (Puig et al.,
2001) with modifications as described below. Type I GT1 strain parasites
were transfected with a plasmid containing yellow fluorescent protein (YFP)
fused to the N terminus of the Escherichia coli Tn10 tet-repressor (TetR) and
driven by chloramphenicol selection (provided by Dick Schaap). Clonal cell
lines were isolated and served as the parental lines for the Tet-inducible
TAP-tag system. Plasmids for the inducible TAP-tag system were generated
by fusion of a Tet-repressible T. gondii RPS13 promoter (van Poppel et al.,
2006) to a multiple cloning site (MCS) and followed by an in-frame C-terminal
fusion to a calmodulin-binding peptide linked to protein A by a TEV cleavage
site and containing a Ble selectable marker.
TAP-tagged parasites were grown in mouse L929 cells in RPMI with
5% fetal bovine serum (FBS) supplemented with 2 mM L-glutamine and
20 mg/ml gentamicin grown at 37C in 5% CO2 (complete medium).
Following induction, harvested parasites were subjected to sonication in
extraction buffer, and the lysate was incubated with Fast Flow Agarose-
IgG beads (GE Healthcare). The column was treated with TEV protease
(Invitrogen) to release the TAP-tagged protein, which was then bound to
calmodulin agarose beads (Agilent) in the presence of calcium and eluted
with EGTA.
MS Analyses
TAP elution fractions were subjected to proteolysis using trypsin and LysC,
and peptides were captured using Vivapure C18 Micro spin columns
(Vivascience). Peptides were analyzed using an LTQ Orbitrap Velos mass
spectrometer (Thermo Fisher Scientific) coupledwith aNanoLCUltra (Eksigent
Technologies). Data were processed using Mascot Distiller v2.2 and searched
using Mascot Daemon 2.2 (Matrix Science). Searches were performed against
the Toxoplasma gondii database (v6.1) and NCBI nonredundant database
(January 2011; 12,679,685 entries).
Statistical Analyses
Statistical analyses were conducted with GraphPad (Prism5) using Student’s
t tests (two-tailed, unpaired samples, equal variance).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.chom.2014.04.002.
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